Literature DB >> 10746610

Expression and functional activity of heat shock proteins in human glioblastoma multiforme.

M Hermisson1, H Strik, J Rieger, J Dichgans, R Meyermann, M Weller.   

Abstract

OBJECTIVE: To assess the expression of heat shock proteins (HSP) in glioma cells in vitro and in vivo and to examine their role in resistance to apoptosis.
BACKGROUND: HSP are expressed in response to various forms of stress. Constitutive HSP expression may confer resistance to cytotoxic stimuli in human cancers.
METHODS: HSP expression was assessed by immunoblot analysis in glioma cells in vitro and by immunocytochemistry in human glioblastomas in vivo. Modulation of apoptosis by hyperthermia-mediated HSP induction was examined in glioma cell lines in vitro.
RESULTS: Immunoblot analysis revealed constitutive expression of HSP27, HSP72, HSP73, and HSP90 in all 12 human glioma cell lines. B-crystallin (alphaBC) was expressed in 3 of 12 cell lines. High levels of alphaBC and HSP72 correlated with drug resistance and high p53 levels in vitro. Transient hyperthermia (43 degrees C/2 hours) induced HSP27 and HSP72 expression but had no effect on the levels of alphaBC, HSP73, or HSP90. HSP induction provided no survival advantage against subsequent cytotoxic challenges, including cytotoxic cytokines and radiochemotherapy. Immunohistochemistry showed strong expression of all HSP in vivo. The comparative analysis of HSP27, alphaBC, HSP72, HSP73, and HSP90 expression in 24 paired samples of first resections and recurrences of human glioblastoma multiforme revealed no impact of HSP expression on response to adjuvant radiochemotherapy and no modulation of HSP expression by radiochemotherapy.
CONCLUSIONS: High constitutive, as opposed to inducible, expression of HSP may play a role in the primary resistance of human malignant gliomas to cytotoxic radiochemotherapy. Superinduction of HSP levels by hyperthermia in vitro provided no further survival advantage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746610     DOI: 10.1212/wnl.54.6.1357

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer.

Authors:  Robert Farkas; Eva Pozsgai; Andrew V Schally; Andras Szigeti; Edit Szigeti; Zoltan Laszlo; Andras Papp; Eva Gomori; Laszlo Mangel; Peter O Horvath; Szabolcs Bellyei
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-08       Impact factor: 4.553

Review 2.  Vaccination in the immunotherapy of glioblastoma.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

3.  Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis.

Authors:  Guobo Shen; Shufang Liang; Zhizhong Xu; Liangxue Zhou; Shiyin Xiao; Xiangying Xia; Ronghui Li; Ying Liao; Chao You; Yuquan Wei
Journal:  Proteome Sci       Date:  2010-03-26       Impact factor: 2.480

Review 4.  [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles].

Authors:  M Platten; W Wick
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 5.  Vaccine strategies for glioblastoma: progress and future directions.

Authors:  Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal:  Immunotherapy       Date:  2013-02       Impact factor: 4.196

6.  Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.

Authors:  Jun Thorsteinsdottir; Stefan Stangl; Peng Fu; Ketai Guo; Valerie Albrecht; Sabina Eigenbrod; Janina Erl; Mathias Gehrmann; Jörg-Christian Tonn; Gabriele Multhoff; Christian Schichor
Journal:  J Neurooncol       Date:  2017-08-28       Impact factor: 4.130

7.  Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol.

Authors:  Juliana de Saldanha da Gama Fischer; Lujian Liao; Paulo C Carvalho; Valmir C Barbosa; Gilberto B Domont; Maria da Gloria da Costa Carvalho; John R Yates
Journal:  J Proteomics       Date:  2010-01-18       Impact factor: 4.044

Review 8.  Cellular and vaccine therapeutic approaches for gliomas.

Authors:  Michelle J Hickey; Colin C Malone; Kate L Erickson; Martin R Jadus; Robert M Prins; Linda M Liau; Carol A Kruse
Journal:  J Transl Med       Date:  2010-10-14       Impact factor: 5.531

9.  Expression of αB-crystallin overrides the anti-apoptotic activity of XIAP.

Authors:  Jee Suk Lee; Hye Young Kim; Na Young Jeong; Sang Yeob Lee; Young Geol Yoon; Yung Hyun Choi; Chunlan Yan; In-Sun Chu; Hyungjong Koh; Hwan Tae Park; Young Hyun Yoo
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

10.  Regulation and function of aquaporin-1 in glioma cells.

Authors:  Yasuhiko Hayashi; Nancy A Edwards; Martin A Proescholdt; Edward H Oldfield; Marsha J Merrill
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.